Quarterly
Annual
| Unit: USD | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||||||||||
net income | -477,052,000 | -199,781,000 | -133,674,000 | -147,722,000 | -153,596,000 | -425,764,000 | -217,828,000 | -169,094,000 | -222,066,000 | -236,234,000 | -172,997,000 | -152,941,000 | -159,416,000 | -267,567,000 | -143,231,000 | -120,224,000 | -147,039,000 | -117,469,000 | -119,681,460 | -124,540 | 760,031 | 887,754 | 809,791 |
less: income from discontinued operations | 0 | 0 | |||||||||||||||||||||
income from continuing operations | -477,052,000 | -199,781,000 | -133,674,000 | -147,722,000 | -153,596,000 | -425,764,000 | |||||||||||||||||
adjustments to reconcile net income from continuing operations to net cash from operating activities: | |||||||||||||||||||||||
depreciation and amortization | 12,610,000 | 11,720,000 | 11,092,000 | 10,596,000 | 7,132,000 | 16,996,000 | 4,710,000 | 7,052,000 | 6,828,000 | 6,796,000 | 6,565,000 | 3,111,000 | 2,272,000 | 2,249,000 | 1,905,000 | 1,805,000 | 1,753,000 | 1,443,000 | |||||
stock-based compensation | 6,632,000 | 8,601,000 | 7,950,000 | 8,786,000 | 6,475,000 | 18,659,000 | 25,709,000 | 24,548,000 | 44,191,000 | 102,845,000 | 54,841,000 | 53,528,000 | 53,728,000 | 49,047,000 | 52,670,000 | 50,266,000 | 46,255,000 | 52,196,000 | |||||
equity in net income of affiliates | 765,000 | -173,000 | 881,000 | 157,000 | 131,000 | 262,000 | 7,617,000 | 8,408,000 | 14,591,000 | 1,984,000 | 1,270,000 | 2,820,000 | 513,000 | 1,147,000 | |||||||||
revaluation of financial instruments | 3,812,000 | 8,431,000 | -2,973,000 | 826,000 | 10,457,000 | 187,226,000 | 8,137,000 | -231,000 | -51,000 | -286,000 | |||||||||||||
revaluation of contingent stock consideration | 0 | -41,509,000 | |||||||||||||||||||||
inventory write-downs | 31,390,000 | 19,011,000 | 17,532,000 | 20,044,000 | 6,718,000 | 51,782,000 | 10,279,000 | 2,439,000 | 4,441,000 | 5,727,000 | 7,417,000 | 3,473,000 | |||||||||||
impairment expense | 303,339,000 | ||||||||||||||||||||||
inducement expense | |||||||||||||||||||||||
non-cash interest expense | 7,594,000 | 4,071,000 | 4,210,000 | 3,625,000 | 6,355,000 | 53,483,000 | 9,355,000 | 10,008,000 | 6,591,000 | 6,433,000 | |||||||||||||
loss on supplier deposits | 10,401,000 | 716,000 | |||||||||||||||||||||
gain on divestiture of affiliate | 0 | 0 | |||||||||||||||||||||
loss on debt extinguishment | 2,820,000 | 871,000 | 10,663,000 | 0 | |||||||||||||||||||
net incomees on asset sales and disposals | |||||||||||||||||||||||
other non-cash activity | 186,000 | 1,994,000 | 809,000 | 2,871,000 | 455,000 | 2,873,000 | -83,000 | 1,098,000 | 1,118,000 | 203,000 | 599,000 | -326,000 | |||||||||||
changes in operating assets and liabilities: | |||||||||||||||||||||||
accounts receivable | 18,392,000 | -11,933,000 | -15,974,000 | -5,892,000 | -7,267,000 | 9,292,000 | 7,611,000 | 4,029,000 | 6,153,000 | -20,936,000 | -15,387,000 | -1,339,000 | 137,000 | 175,000 | |||||||||
inventory | -28,319,000 | -32,953,000 | -20,344,000 | -17,788,000 | -13,773,000 | -21,708,000 | 14,597,000 | -2,872,000 | -22,954,000 | -37,484,000 | -38,064,000 | -22,404,000 | -13,768,000 | -1,377,000 | |||||||||
prepaid expenses and other current assets | 8,548,000 | 6,012,000 | -9,732,000 | -10,297,000 | 3,600,000 | 251,000 | -40,014,000 | -8,569,000 | 1,865,000 | 2,260,000 | 2,079,000 | -14,710,000 | -3,877,000 | -3,066,000 | -2,266,000 | -1,758,000 | -1,252,000 | 870,000 | |||||
long-term deposits | 99,000 | 16,000 | 0 | -84,000 | 4,050,000 | -75,000 | -4,161,000 | ||||||||||||||||
other assets | 192,000 | -633,000 | -573,000 | -389,000 | 854,000 | -343,000 | -112,000 | -1,929,000 | 103,000 | -304,000 | -304,000 | -304,000 | |||||||||||
accounts payable, accrued expenses and other current liabilities | -25,422,000 | -9,712,000 | -5,585,000 | 11,819,000 | -12,941,000 | 57,802,000 | -3,958,000 | -55,516,000 | 9,107,000 | 9,733,000 | 17,526,000 | -2,131,000 | -51,016,000 | 137,625,000 | 7,452,000 | 2,083,000 | 10,266,000 | ||||||
operating lease liabilities | -854,000 | -1,030,000 | -976,000 | -763,000 | -818,000 | -412,000 | -169,000 | -610,000 | -458,000 | -139,000 | -200,000 | -77,000 | |||||||||||
other long-term liabilities | -1,870,000 | 12,929,000 | 10,299,000 | 5,836,000 | 7,400,000 | -781,000 | 1,819,000 | 1,278,000 | 1,244,000 | 1,829,000 | 233,000 | -457,000 | 49,302,000 | ||||||||||
net cash from operating activities | -121,971,000 | -149,377,000 | -134,553,000 | -115,603,000 | -117,754,000 | -91,259,000 | -107,204,000 | -179,961,000 | -145,247,000 | -157,648,000 | -142,488,000 | -131,323,000 | -111,785,000 | -69,395,000 | -66,725,000 | -59,249,000 | -65,631,000 | -39,117,000 | -45,248,778 | -536,222 | |||
capex | -2,128,000 | 1,199,000 | 0 | 0 | 2,532,000 | -6,234,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6,281,000 | 27,108,000 | 0 | -1,998,000 | 0 | 0 | |||
free cash flows | -124,099,000 | -148,178,000 | -134,553,000 | -115,603,000 | -115,222,000 | -97,493,000 | -107,204,000 | -179,961,000 | -145,247,000 | -157,648,000 | -142,488,000 | -131,323,000 | -111,785,000 | -69,395,000 | -60,444,000 | -32,141,000 | -65,631,000 | -41,115,000 | -45,248,778 | -536,222 | |||
cash flows from investing activities | |||||||||||||||||||||||
purchases and deposits for property, plant and equipment | |||||||||||||||||||||||
divestiture of affiliates | |||||||||||||||||||||||
proceeds from the sale of assets | 408,000 | 0 | 0 | 21,398,000 | 0 | ||||||||||||||||||
payments to assignee | 0 | -1,000 | |||||||||||||||||||||
investments in affiliates | 0 | -166,000 | 0 | 0 | -19,679,000 | -3,348,000 | 0 | 0 | |||||||||||||||
net cash from investing activities | -2,867,000 | -13,558,000 | -13,724,000 | 4,940,000 | -11,107,000 | -115,000 | -3,238,000 | -52,289,000 | -51,306,000 | -79,600,000 | -56,889,000 | -33,454,000 | -69,001,000 | -48,893,000 | -65,066,000 | -24,521,000 | -15,946,000 | -8,892,000 | -245,183,000 | 238,880,000 | 474,627 | ||
cash flows from financing activities | |||||||||||||||||||||||
proceeds from issuance of common stock under equity distribution agreements, net of commissions and other fees paid | |||||||||||||||||||||||
proceeds from issuances of convertible debt instruments, net of discount and issuance costs | |||||||||||||||||||||||
proceeds from insurance premium financing | 1,188,000 | 0 | 0 | 1,314,000 | 0 | ||||||||||||||||||
proceeds from public offerings, net of underwriter's discount | |||||||||||||||||||||||
proceeds from issuance of shares under the tumim purchase agreements | 0 | 0 | 2,874,000 | 64,713,000 | 0 | 96,296,000 | 27,376,000 | ||||||||||||||||
proceeds from registered direct offering, net of underwriter's discount | -210,000 | ||||||||||||||||||||||
proceeds from the exercise of stock options | 2,000 | 6,353,000 | 636,000 | 404,000 | 5,222,000 | 1,080,000 | 257,000 | 308,000 | 591,000 | 355,000 | 1,213,000 | 2,626,000 | 7,446,000 | 320,000 | |||||||||
proceeds from issuance of financing obligations, net of issuance costs | |||||||||||||||||||||||
repayment of senior convertible notes | |||||||||||||||||||||||
payments on finance lease liabilities and financing obligation | -1,288,000 | -1,276,000 | -856,000 | -204,000 | 235,000 | -490,000 | -248,000 | -74,000 | |||||||||||||||
payments on insurance premium financing | -1,439,000 | -1,808,000 | 0 | -1,853,000 | -1,819,000 | -1,169,000 | -382,000 | -1,999,000 | -2,003,000 | ||||||||||||||
payment for coupon make-whole premiums | |||||||||||||||||||||||
repayments of collateralized promissory notes | |||||||||||||||||||||||
other financing activities | |||||||||||||||||||||||
net cash from financing activities | 28,689,000 | 98,080,000 | 52,646,000 | -5,055,000 | 230,726,000 | 188,119,000 | 208,530,000 | 115,608,000 | 115,727,000 | 111,814,000 | 343,483,000 | 27,654,000 | 116,041,000 | 72,580,000 | 735,000 | -1,758,000 | 8,373,000 | 263,209,000 | 669,116,000 | 422,000 | |||
net increase in cash and cash equivalents and restricted cash and cash equivalents | |||||||||||||||||||||||
cash and cash equivalents, including restricted cash and cash equivalents, beginning of period | 0 | 0 | 0 | 493,965,000 | 0 | 0 | -9,055,000 | 322,964,000 | |||||||||||||||
cash and cash equivalents, including restricted cash and cash equivalents, end of period | -96,149,000 | -64,855,000 | -95,631,000 | 378,247,000 | 101,865,000 | 96,745,000 | 89,033,000 | 206,322,000 | |||||||||||||||
cash flows from discontinued operations: | |||||||||||||||||||||||
operating activities | 0 | 0 | |||||||||||||||||||||
investing activities | 0 | 0 | |||||||||||||||||||||
financing activities | 0 | 0 | |||||||||||||||||||||
net cash from discontinued operations | 0 | 0 | |||||||||||||||||||||
supplemental cash flow disclosures: | |||||||||||||||||||||||
cash paid for interest | 4,195,000 | 8,518,000 | 2,766,000 | 2,680,000 | 185,000 | 187,000 | 267,000 | 192,000 | |||||||||||||||
cash interest received | 1,635,000 | 2,973,000 | 4,369,000 | 3,558,000 | 125,000 | 259,000 | -184,000 | 408,000 | |||||||||||||||
supplemental noncash investing and financing activities: | |||||||||||||||||||||||
conversion of toggle convertible notes | |||||||||||||||||||||||
conversion of senior convertible notes into common stock | 30,362,000 | 0 | |||||||||||||||||||||
conversion of 8.25% convertible notes | -1,000 | 75,000 | |||||||||||||||||||||
leased assets obtained in exchange for new finance lease liabilities | 12,311,000 | 0 | 21,838,000 | ||||||||||||||||||||
toggle convertible notes issued for paid in kind interest | |||||||||||||||||||||||
purchases of property, plant and equipment included in liabilities | -2,128,000 | 1,199,000 | 2,532,000 | -6,234,000 | 6,281,000 | 27,108,000 | |||||||||||||||||
accrued commissions under equity distribution agreement | 278,000 | 536,000 | -1,065,000 | 323,000 | |||||||||||||||||||
accrued pik interest | |||||||||||||||||||||||
reclassification of conversion features embedded in toggle convertible notes to equity | 0 | ||||||||||||||||||||||
embedded derivative liability bifurcated from 8.25% convertible notes | |||||||||||||||||||||||
contingent stock consideration for divestiture of affiliate | 0 | 0 | |||||||||||||||||||||
embedded derivative liability bifurcated from april 2023 toggle convertible notes | 0 | 0 | |||||||||||||||||||||
reclassification from liability to equity for certain share-based awards | 0 | ||||||||||||||||||||||
reclassification from equity to liability for certain share-based awards | 0 | 8,395,000 | |||||||||||||||||||||
accrued debt and equity issuance costs | |||||||||||||||||||||||
loss on disposal of assets | -237,000 | 470,000 | 2,688,000 | ||||||||||||||||||||
purchases and deposits of property, plant and equipment | -13,558,000 | -13,724,000 | -16,458,000 | -20,690,000 | -35,430,000 | -52,289,000 | -51,120,000 | -37,210,000 | -30,106,000 | -48,893,000 | -40,266,000 | -24,521,000 | |||||||||||
divestiture of affiliate | 0 | ||||||||||||||||||||||
investments in affiliate | |||||||||||||||||||||||
proceeds from public offering, net of underwriter's discount | |||||||||||||||||||||||
proceeds from issuance of common stock under equity distribution agreement, net of commissions and other fees paid | 21,263,000 | ||||||||||||||||||||||
proceeds from issuance of convertible notes | |||||||||||||||||||||||
proceeds from issuance of financing obligation, net of issuance costs | 3,943,000 | 5,425,000 | |||||||||||||||||||||
repayment of debt and promissory notes | -261,000 | -131,000 | -130,000 | -40,230,000 | -2,513,000 | -2,544,000 | |||||||||||||||||
payment for coupon make-whole premium | -49,000 | -2,783,000 | -1,747,000 | ||||||||||||||||||||
payments on finance lease liabilities and financing obligations | |||||||||||||||||||||||
payments for issuance costs | -49,000 | -400,000 | -218,000 | -26,000 | |||||||||||||||||||
net increase in cash and cash equivalents, including restricted cash and cash equivalents | 96,745,000 | ||||||||||||||||||||||
supplementary cash flow disclosures: | |||||||||||||||||||||||
supplementary disclosures for noncash investing and financing activities: | |||||||||||||||||||||||
pik interest | 3,821,000 | 2,089,000 | |||||||||||||||||||||
conversion of april 2023 toggle convertible notes | 0 | ||||||||||||||||||||||
accrued issuance costs | |||||||||||||||||||||||
proceeds from issuance of convertible notes, net of discount and issuance costs | 165,000,000 | 49,710,000 | -6,000 | ||||||||||||||||||||
net decrease in cash and cash equivalents, including restricted cash and cash equivalents | -95,631,000 | -115,718,000 | -116,642,000 | ||||||||||||||||||||
proceeds from issuance of common stock under equity distribution agreement, net of commissions paid | 866,000 | 53,462,000 | 31,041,000 | 30,524,000 | 64,631,000 | ||||||||||||||||||
non-cash in-kind services | 6,041,000 | 12,507,000 | 14,827,000 | 12,896,000 | 17,087,000 | 11,401,000 | |||||||||||||||||
issuance of common stock for commitment shares | 0 | 2,939,000 | |||||||||||||||||||||
issuance of senior secured note receivable and prepaid acquisition-related consideration | -5,881,000 | ||||||||||||||||||||||
settlement of price differentials | |||||||||||||||||||||||
proceeds from issuance of debt, promissory notes and notes payable, net of issuance costs | |||||||||||||||||||||||
repayment of debt, promissory notes and notes payable | |||||||||||||||||||||||
net assets acquired in romeo acquisition | |||||||||||||||||||||||
toggle unsecured convertible notes issued for paid in kind interest | |||||||||||||||||||||||
embedded derivative asset bifurcated from convertible notes | |||||||||||||||||||||||
stock option proceeds receivable | |||||||||||||||||||||||
common stock issued for commitment shares | |||||||||||||||||||||||
common stock issued for investments in affiliates, including common stock with embedded put right | |||||||||||||||||||||||
acquired intangible assets included in liabilities | |||||||||||||||||||||||
settlement of second price differential | |||||||||||||||||||||||
proceeds from issuance of collateralized promissory notes | |||||||||||||||||||||||
embedded derivative asset bifurcated from june 2022 toggle convertible notes | |||||||||||||||||||||||
accrued debt issuance costs | |||||||||||||||||||||||
accrued deferred issuance costs | 22,000 | 330,000 | |||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||
proceeds from registered direct offering, net of underwriters discount | |||||||||||||||||||||||
proceeds from public offering, net of underwriters discount | |||||||||||||||||||||||
conversion of 5% senior convertible notes into common stock | |||||||||||||||||||||||
proceeds from issuance of 5% senior convertible notes | 25,000,000 | ||||||||||||||||||||||
loss on forward contract liability | 0 | 0 | |||||||||||||||||||||
cash and restricted cash acquired in romeo acquisition | |||||||||||||||||||||||
proceeds from sale of equipment | 0 | 0 | 0 | ||||||||||||||||||||
proceeds from issuance of series d redeemable convertible preferred stock, net of issuance costs paid | 0 | 0 | |||||||||||||||||||||
business combination and pipe financing, net of issuance costs paid | 0 | -10,000 | |||||||||||||||||||||
proceeds from the exercise of stock warrants, net of issuance costs paid | 1,484,000 | ||||||||||||||||||||||
proceeds from issuance of shares under the tumim purchase agreement | |||||||||||||||||||||||
repayment of debt and notes | |||||||||||||||||||||||
net decrease in cash and cash equivalents, including restricted cash | -137,123,000 | -85,528,000 | |||||||||||||||||||||
cash and cash equivalents, including restricted cash, beginning of period | 0 | 0 | 522,241,000 | 0 | 0 | 849,278,000 | 0 | ||||||||||||||||
cash and cash equivalents, including restricted cash, end of period | -125,434,000 | 144,106,000 | 385,118,000 | -45,708,000 | -131,056,000 | 763,750,000 | 215,200,000 | ||||||||||||||||
proceeds from issuance of collateralized promissory note | |||||||||||||||||||||||
repayment of promissory note | |||||||||||||||||||||||
net increase in cash and cash equivalents, including restricted cash | -45,708,000 | 215,200,000 | |||||||||||||||||||||
revaluation of warrant liability | 434,000 | -144,000 | -4,467,000 | 2,511,000 | -951,000 | ||||||||||||||||||
payments on finance lease liabilities | -30,000 | -241,000 | |||||||||||||||||||||
payment of note payable | 0 | 0 | 0 | -4,100,000 | 0 | 0 | |||||||||||||||||
revaluation of series a redeemable convertible preferred stock warrant liability | |||||||||||||||||||||||
long-term and customer deposits | -16,000 | 2,542,000 | |||||||||||||||||||||
settlement of first price differential | |||||||||||||||||||||||
cash paid towards build-to-suit lease | |||||||||||||||||||||||
proceeds from the exercise of series a redeemable convertible preferred stock warrants | |||||||||||||||||||||||
repurchase of series b redeemable convertible preferred stock from related parties, net of issuance costs paid | |||||||||||||||||||||||
proceeds from landlord on finance lease | |||||||||||||||||||||||
payments on finance lease liability | -258,000 | ||||||||||||||||||||||
proceeds from issuance of promissory note, net of issuance costs | |||||||||||||||||||||||
proceeds from note payable | 0 | 0 | 3,712,000 | 422,000 | |||||||||||||||||||
payment for issuance costs | |||||||||||||||||||||||
deferred income taxes | 0 | 1,000 | 1,000 | -1,067,000 | 2,000 | 103,521 | -101,521 | -41,295 | 98,273 | ||||||||||||||
revaluation of derivative liability | |||||||||||||||||||||||
loss on sale of equipment | 0 | ||||||||||||||||||||||
proceeds from issuance of common stock under stock purchase agreement | |||||||||||||||||||||||
proceeds from landlord of finance lease | 0 | ||||||||||||||||||||||
non-cash prepaid in-kind services | -17,087,000 | -11,400,000 | |||||||||||||||||||||
accrued business combination and pipe transaction costs | 0 | -10,000 | |||||||||||||||||||||
net liabilities assumed from vectoiq | |||||||||||||||||||||||
equity in net income of affiliate | 794,000 | ||||||||||||||||||||||
accrued series d redeemable convertible preferred stock issuance costs | |||||||||||||||||||||||
non-cash interest income | |||||||||||||||||||||||
cash paid for acquisitions, net of cash acquired | |||||||||||||||||||||||
issuance of related party note receivable | |||||||||||||||||||||||
purchases and deposits for property and equipment | |||||||||||||||||||||||
proceeds from issuance of series c redeemable convertible preferred stock, net of issuance costs paid | |||||||||||||||||||||||
cash paid for income taxes, net of refunds | |||||||||||||||||||||||
non-cash interest received related to related party notes | |||||||||||||||||||||||
non-cash settlement of related party note receivable | |||||||||||||||||||||||
accrued purchases of property and equipment | |||||||||||||||||||||||
property acquired through build-to-suit lease | |||||||||||||||||||||||
non-cash acquisition of license | |||||||||||||||||||||||
non-cash series c redeemable convertible preferred stock issuance costs | |||||||||||||||||||||||
net liabilities assumed by vectoiq | |||||||||||||||||||||||
settlement of forward contract liability | 0 | ||||||||||||||||||||||
customer deposits | 1,931,000 | ||||||||||||||||||||||
purchases of property and equipment | -1,998,000 | ||||||||||||||||||||||
deposits for property and equipment | -6,879,000 | ||||||||||||||||||||||
investment in joint venture | |||||||||||||||||||||||
payments to landlord for finance lease | -165,000 | ||||||||||||||||||||||
accrued purchases and deposits of property and equipment | 765,000 | ||||||||||||||||||||||
net liabilities assumed from vectoiq in business combination | |||||||||||||||||||||||
accounts payable and accrued expenses and other current liabilities | |||||||||||||||||||||||
cash flows from operating activities: | |||||||||||||||||||||||
investment income earned on marketable securities held in trust account | -507,040 | ||||||||||||||||||||||
change in operating assets and liabilities: | |||||||||||||||||||||||
decrease in prepaid expenses | 15,625 | 15,625 | |||||||||||||||||||||
decrease in accounts payable and accrued liabilities | -105,323 | ||||||||||||||||||||||
increase in accrued income tax payable | 286,577 | 187,729 | |||||||||||||||||||||
cash flows from investing activities: | |||||||||||||||||||||||
purchases of investments held in trust account | |||||||||||||||||||||||
maturities of marketable securities held in trust account | 238,880,000 | 473,570,000 | 1,448,000 | 236,000,000 | |||||||||||||||||||
cash flows from financing activities: | |||||||||||||||||||||||
net change in cash and cash and equivalents held in trust account | 238,765,778 | ||||||||||||||||||||||
cash and cash equivalents held in trust account - beginning of period | 761,956 | ||||||||||||||||||||||
cash and cash equivalents held in trust account - end of period | 239,527,734 | ||||||||||||||||||||||
decrease (increase) in prepaid expenses | 15,625 | ||||||||||||||||||||||
increase in accounts payable and accrued liabilities | |||||||||||||||||||||||
decrease in accrued income tax payable | |||||||||||||||||||||||
proceeds from issuance of common stock, net of offering costs | |||||||||||||||||||||||
deferred offering cost | |||||||||||||||||||||||
net change in cash and cash held in trust account | |||||||||||||||||||||||
cash and cash held in trust account - beginning of period | 0 | 0 | 1,216,579 | ||||||||||||||||||||
cash and cash held in trust account - end of period | 82,288 | -86,656 | 882,400 | ||||||||||||||||||||
assets: | |||||||||||||||||||||||
cash | 28,963 | 21,517 | 9,716 | ||||||||||||||||||||
u.s. government treasury bills | 796,944 | 148,220 | 236,631,289 | ||||||||||||||||||||
total | 825,907 | 169,737 | 236,641,005 | ||||||||||||||||||||
supplemental disclosure of non-cash financing activities: | |||||||||||||||||||||||
offering costs included in accounts payable | |||||||||||||||||||||||
supplemental disclosure of noncash investing and financing activities: | |||||||||||||||||||||||
deferred offering costs included in accounts payable | |||||||||||||||||||||||
cash flow from operating activities: | |||||||||||||||||||||||
payments on notes payable | |||||||||||||||||||||||
net increase in cash and cash held in trust account | |||||||||||||||||||||||
cash and cash held in trust account—beginning of period | |||||||||||||||||||||||
cash and cash held in trust account—end of period | |||||||||||||||||||||||
54 | |||||||||||||||||||||||
cash held in trust account |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
